ARHGAP26

ARHGAP26
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
Aliases ARHGAP26, GRAF, GRAF1, OPHN1L, OPHN1L1, Rho GTPase activating protein 26
External IDs MGI: 1918552 HomoloGene: 36349 GeneCards: ARHGAP26
RNA expression pattern




More reference expression data
Orthologs
Species Human Mouse
Entrez

23092

71302

Ensembl

ENSG00000145819

ENSMUSG00000036452

UniProt

Q9UNA1

Q6ZQ82

RefSeq (mRNA)

NM_001135608
NM_015071

NM_175164

RefSeq (protein)

NP_001129080.1
NP_055886.1

NP_780373.3

Location (UCSC) Chr 5: 142.77 – 143.23 Mb Chr 18: 38.6 – 39.38 Mb
PubMed search [1] [2]
Wikidata
View/Edit HumanView/Edit Mouse

Rho GTPase activating protein 26 (ARHGAP26) also known as GTPase Regulator Associated with Focal Adhesion Kinase (GRAF) is a protein that in humans is encoded by the ARHGAP26 gene.[3][4][5]

Function

GRAF1 is a multidomain protein that is necessary for the CLIC/GEEC endocytic pathway.[6] By virtue of an N-terminal BAR domain, GRAF1 sculpts the endocytic membranes of this pathway into 40 nm diameter tubules and vesicles that allow uptake of extracellular fluid, GPI-linked proteins and certain bacterial exotoxins into cells. The role of dynamin in the CLIC/GEEC pathway is controversial, but GRAF1 interacts strongly with this protein and acute inhibition of dynamin action abrogates CLIC/GEEC endocytosis. There are several members of the GRAF family of proteins, including GRAF2, GRAF3, and oligophrenin, all of which likely playing similar roles during clathrin-independent endocytic events. Mutations of both GRAF1 and oligophrenin are strongly implicated in causing human disease (leukaemia and mental retardation, respectively). Recently, autoantibodies to ARHGAP26 have been implicated in autoimmune cerebellar ataxia.[7][8][9]

Interactions

ARHGAP26 has been shown to interact with PKN3.[10]

References

  1. "Human PubMed Reference:".
  2. "Mouse PubMed Reference:".
  3. "Entrez Gene: ARHGAP26 Rho GTPase activating protein 26".
  4. Hildebrand JD, Taylor JM, Parsons JT (June 1996). "An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase". Mol. Cell. Biol. 16 (6): 3169–78. PMC 231310Freely accessible. PMID 8649427.
  5. Taylor JM, Macklem MM, Parsons JT (January 1999). "Cytoskeletal changes induced by GRAF, the GTPase regulator associated with focal adhesion kinase, are mediated by Rho". J. Cell. Sci. 112 ( Pt 2): 231–42. PMID 9858476.
  6. Lundmark R, Doherty GJ, Howes MT, Cortese K, Vallis Y, Parton RG, McMahon HT (November 2008). "The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway". Curr. Biol. 18 (22): 1802–8. doi:10.1016/j.cub.2008.10.044. PMC 2726289Freely accessible. PMID 19036340.
  7. Jarius S, Wandinger KP, Horn S, Heuer H, Wildemann B (Mar 2012). "A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization". J Neuroinflammation. 7 (7): 21. doi:10.1186/1742-2094-7-21. PMID 20226058. Check date values in: |year= / |date= mismatch (help)
  8. Jarius S, Martínez-García P, Hernandez AL, Brase JC, Borowski K, Regula JU, Meinck HM, Stöcker W, Wildemann B, Wandinger KP (Jan 2013). "Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia". J Neuroinflammation. 10 (10): 7. doi:10.1186/1742-2094-10-7. PMID 23320754.
  9. Doss S, Nümann A, Ziegler A, Siebert E, Borowski K, Stöcker W, Prüss H, Wildemann B, Endres M, Jarius S (15 Feb 2014). "Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline". J. Neuroimmunol. 267 (1-2): 102–4. doi:10.1016/j.jneuroim.2013.10.010. PMID 24439423.
  10. Shibata H, Oishi K, Yamagiwa A, Matsumoto M, Mukai H, Ono Y (2001). "PKNbeta interacts with the SH3 domains of Graf and a novel Graf related protein, Graf2, which are GTPase activating proteins for Rho family". J. Biochem. 130 (1): 23–31. doi:10.1093/oxfordjournals.jbchem.a002958. PMID 11432776.

Further reading

External links


This article is issued from Wikipedia - version of the 10/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.